跳至主要内容
临床试验/JPRN-UMIN000026706
JPRN-UMIN000026706尚未招募2 期

Carboplatin with nab-paclitaxel as first-line therapy in patients with advanced non-small-cell lung cancer and idiopathic interstitial pneumonias - Carboplatin with nab-paclitaxel as first-line therapy in patients with advanced non-small-cell lung cancer and idiopathic interstitial pneumonias

Kurashiki Central Hospital Department of Respiratory medicine0 个研究点目标入组 32 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) with interstitial pneumonias secondary to other conditions 2) with history of acute exacerbations of interstitial pneumonias within 3 months 3) with history of subacute exacerbations of interstitial pneumonias within 3 months 4) with usage of immunosuppressants 5) with peripheral neuropathy with Grade 2-4 6) with allergy to carboplatin, albumin, or taxane-based anticancer agents 7) with active infectious diseases 8) with active double cancers 9) with clinically important complications 10) with positivity of HBs antigen

研究者

发起方
Kurashiki Central Hospital Department of Respiratory medicine

相似试验